RSS Feeds
The Promotion of Gabapentin
- Eric D. Peterson, EdM;
- Kurt Boyce; and
- Karen Overstreet, EdD
- From North American Association of Medical Education and Communication Companies, Birmingham, Alabama.
TO THE EDITOR:
Steinman and colleagues (1) offered a purportedly “unique window for understanding the structure and methods of pharmaceutical promotion,” concluding that “[n]ew strategies are needed to ensure a clear separation between scientific and commercial activity.” The authors explored the well-documented abuses related to the off-label marketing of gabapentin. Unfortunately, they seem to imply that these actions are representative of current practice. Worse, the authors call for various reforms but seem unaware that many such reforms have already taken place. They state only that “a complex system has …
